Pelargonium sidoides preparation EPs 7630 in COPD: health-related quality of life and other patient-reported outcomes in adults receiving add-on therapy.

CONCLUSIONS: Add-on therapy with EPs 7630 led to an improvement in HRQL and other PRO in adult patients with COPD compared to placebo while showing a good long-term tolerability. PMID: 29231073 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research